US › Healthcare

Baird Medical Investment Holdings Limited (BDMD)

US · Healthcare · Medical Devices

$1.04-1.89%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$9.9M

Revenue YoY

-58.5%

Net profit

$13,499

Profit YoY

-99.8%

EPS

$-0.43

EPS estimate

$0.00

Net margin

0.1%

Key statistics

Market cap

$34.5M

Forward P/E

7.9

P/B

1.01

Book value

$1.52

EPS (TTM)

$-0.54

52-week high

$3.70

52-week low

$0.76

50-day MA

$1.12

200-day MA

$1.47

Beta

-1.16

Analyst view

with an average price target of $4.00.

Shareholding

Insiders

64.85%

Institutions

0.75%

Largest institutional holders

Fund	Stake
Highbridge Capital Management, LLC	0.39%
UBS Group AG	0.21%
Two Sigma Investments LLC	0.15%
Jane Street Group LLC	0.12%
Geode Capital Management, LLC	0.08%
Morgan Stanley - Brokerage Accounts	0.06%
NATIONAL BANK OF CANADA /FI/	0.04%
Wolverine Asset Management LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Baird Medical Investment Holdings Limited — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.